Interactions between muscle and the immune system during modified musculoskeletal loading

Clinical Orthopaedics and Related Research

Volumn 403, Issue SUPPL., 2002, Pages

  Tidball, James G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; NITRIC OXIDE;

CELL PROTECTION; CONFERENCE PAPER; HUMAN; IMMUNOPATHOGENESIS; MACROPHAGE; MUSCLE INJURY; MYOSITIS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE REPAIR;

EID: 0036809448     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-200210001-00012     Document Type: Conference Paper

References (69)

1. Akimitsu T, Gute DC, Korthuis RJ: Leukocyte adhesion induced by inhibition of nitric oxide production in skeletal muscle. J Appl Physiol 78:1725-1732, 1995.
2. Albina JE, Cui S, Mateo RB, Reichner JS: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150:5080-5085, 1993.
3. Aljada A, Saadeh R, Assian E, et al: Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab 85:2572-2575, 2000.
4. Almekinders LC, Gilbert JA: Healing of experimental muscle strains and the effects of nonsteroidal antiinflammatory medication. Am J Sports Med 14:303-308, 1986.
5. Armstrong RB: Initial events in exercise-induced muscular injury. Med Sci Sport Exerc 22:429-435, 1990.
6. Beauvais F, Michel L, Dubertret L: Exogenous nitric oxide elicits chemotaxis of neutrophils in vitro. J Cell Physiol 165:610-614, 1995.
7. Billiar TR, Curran RD, Harbrecht BG, et al: Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 48:565-569, 1990.
8. Blaylock MG, Cuthertson BH, Galley HF, et al: The effect of nitric oxide and peroxynitrite on apoptosis in human polymorphonuclear leukocytes. Free Rad Biol Med 25:748-752, 1998.
9. Brenman JE, Chao DS, Xia H, et al: Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82:743-752, 1995.
10. Cambria RA, Anderson RJ, Dikdan G, et al: Leukocyte activation in ischemia-reperfusion injury of skeletal muscle. J Surg Res 51:13-17, 1991.
11. Chang WJ, Iannaccone ST,Lau KS, et al: Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci U S A 93:9142-9147, 1996.
12. Clancy RM, Leszczynska-Piziak J, Abramson SB: Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90:1116-1121, 1992.
13. Dijkstra CD, Dopp EA, Joling P, Kraal G: The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunol 54:589-599, 1985.
14. Disatnik MH, Dhawan J, Yu Y, et al: Evidence of oxidative stress in mdx mouse muscle: Studies of the prenecrotic state. J Neurol Sci 161:77-84, 1998.
15. Faulkner JA, Brooks SV, Opiteck JA: Injury to skeletal muscle fibres during contractions: Conditions of occurrence and prevention. Phys Ther 73:73:911-921, 1993.
16. Fielding RA, Manfredi TJ, Ding W, et al: Acute phase response in exercise: III: Neutrophil and IL-1 beta accumulation in skeletal muscle. Am J Physiol 265:R166-R172, 1993.
17. Formigli L, Lombardo LD, Adembri C, et al: Neutrophils as mediators of human skeletal muscle ischemia-reperfusion syndrome. Hum Pathol 23:627-634, 1992.
18. Frenette J, Cai B, Tidball JG: Complement activation promotes muscle inflammation during modified muscle use. Am J Pathol 156:2103-2110, 2000.
19. Gute DC, Ishida T, Yarimizu K, Korthuis RJ: Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 179:169-187, 1998.
20. Hill J, Lindsay TF, Ortiz F, et al: Soluble complement receptor 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion injury in the rat. J Immunol 149:1723-1728, 1992.
21. Hoffman EP, Brown RH, Kunkel LM: Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51:919-928, 1997.
22. Hutcheson IR, Whittle BJ, Boughton-Smith NK: Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 101:815-820, 1990.
23. Giclas PC, Pinckard RN, Olson MS: In vitro activation of complement by isolated human heart subcellular membranes. J Immunol 122:146-151, 1979.
24. Jolly SR, Kane WJ, Hook BG, et al: Reduction of myocardial infarct size by neutrophil depletion: Effect of duration of occlusion. Am Heart J 112:682-690, 1986.
25. Kawasaki S, Sugiyama S, Ishiguro N, et al: Implication of superoxide radicals on ischemia-reperfusion-induced skeletal muscle injury in rats. Eur Surg Res 25:129-136, 1993.
26. Korthuis RJ, Granger DN: Reactive oxygen metabolites, neutrophils, and the pathogenesis of ischemictissue/reperfusion. Clin Cardiol 16:19-26, 1993.
27. Korthuis RJ, Grisham MB, Granger DN: Leukocyte depletion attenuates vascular injury in postischemic skeletal muscle. Am J Physiol 254:H823-H827, 1988.
28. Kosonen O, Kankaanranta H, Uotila J, Moilanen E: Inhibition by nitric oxide-releasing compounds of E-selectin expression in and neutrophil adhesion to human endothelial cells. Eur J Pharmacol 394:149-156, 2000.
29. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655, 1991.
30. Kyriakides C, Austen W, Wang Y, et al: Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex. Am J Physiol 277:C1263-C1268, 1999.
31. Lefer DJ, Jones SP, Girod WG, et al: Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol 276:H1943-H950, 1999.
32. Linder E, Lehto VP, Stenman S: Activation of complement by cytoskeletal intermediate filaments. Nature 278:176-178, 1979.
33. Lowe DA, Warren GL, Ingalls CP, et al: Muscle function and protein metabolism after initiation of eccentric contraction-induced injury. J Appl Physiol 79:1260-1270, 1995.
34. Lindsay TF, Hill J, Ortiz F, et al: Blockage of complement activation prevents local and pulmonary albumin leak after lower torso ischaemia-reperfusion. Ann Surg 216:677-683, 1992.
35. MacIntyre DL, Reid DW, Lyster DM, et al: Presence of WBC, decreased strength, and delayed soreness in muscle after eccentric exercise. J Appl Physiol 80:1006-1013, 1996.
36. Malm C, Nyberg P, Engstrom M, et al: Immunological changes in human skeletal muscle and blood after eccentric exercise and multiple biopsies. J Physiol 529:243-262, 2000.
37. Massimino ML, Rapizzi E, Cantini M, et al: ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. Biochem Biophys Res Commun 235:754-759, 1997.
38. Matsuda R, Nishikawa A, Tanaka H: Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: Evidence of apoptosis in dystrophin-deficient muscle. J Biochem 118:959-964, 1995.
39. McLennan IS: Resident macrophages (ED2- and ED3-positive) do not phagocytose degenerating rat skeletal muscle fibres. Cell Tissue Res 272:193-196, 1993.
40. Mishra DK, Friden J, Schmitz M, et al: Anti-inflammatory medication after muscle injury. J Bone Joint Surg 77A:1410-1519, 1995.
41. Mitchell DJ, Yu J, Tyml K: Local L-NAME decreases blood flow and increases leukocyte adhesion via CD18. Am J Physiol 274:H1264-H1268, 1998.
42. Mulligan MS, Hevel JM, Marletta MA, Ward PA: Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 88:6338-6342, 1991.
43. Obremsky WT, Seaber AV, Ribbeck BM, et al: Biomechanical and histologic assessment of a controlled muscle strain injury treated with piroxicam. Am J Sport Med 22:558-561, 1994.
44. Petrof BJ, Shrager JB, Stedman HH, et al: Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90:3710-3714, 1993.
45. Rando TA, Disatnik NM, Yu Y, Franco A: Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromusc Disorders 8:14-21, 1998.
46. Riley DA, Ellis S, Giometti S, et al: Muscle sarcomere lesions and thrombosis after spaceflight and suspension unloading. J Appl Physiol 73(Suppl):33S-43S, 1992.
47. Robertson TA, Maley MA, Grounds MD, Papadimitriou JM: The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp Cell Res 207:321-331, 1993.
48. Rubanyi GM, Ho EH, Cantor EH, et al: Cytoprotective function of nitric oxide: Inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 18:1392-1397, 1991.
49. Shingu M, Nobunaga M: Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide. Am J Pathol 117:201-206, 1984.
50. Sicher SC, Vazquez MA, Lu CY: Inhibition of macrophage Ia expression by nitric oxide. J Immunol 153:1293-1300, 1994.
51. Simpson PJ, Lucchesi BR: Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med 110:13-30, 1987.
52. Smith JK, Grisham MB, Granger DN, Korthuis RJ: Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle. Am J Physiol 256:H789-H793, 1989.
53. Smith LL: Acute inflammation: The underlying mechanism in delayed onset muscle soreness? Med Sci Sports Exer 23:542-551, 1991.
54. St Pierre BA, Tidball JG: Differential response of macrophage subpopulations to soleus muscle reloading after rat hindlimb suspension. J Appl Physiol 77:290-297, 1994.
55. Straub V, Rafael JA, Chamberlain JS, Campbell KP: Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 139:375-385, 1997.
56. Street SF: Lateral transmission of tension in frog myofibers: A myofibrillar network and transverse cytoskeletal connections are possible transmitters. J Cell Physiol 114:346-364, 1983.
57. Stupka N, Tarnopolsky MA, Yardley NJ, Phillips SM: Cellular adaptation to repeated eccentric exercise-induced muscle damage. J Appl Physiol 91:1669-1678, 2001.
58. Suzuki K, Totsuka M, Nakaji S, et al: Endurance exercise causes interaction among stress hormones, cytokines, neutrophil dynamics, and muscle damage. J Appl Physiol 87:12360-1367, 1999.
59. Tamir S, Lewis RS, de Rojas Walker T, et al: The influence of delivery rate on the chemistry and biological effects of nitric oxide. Chem Res Toxicol 6:895-899, 1993.
60. Tidball JG: Inflammatory cell response to acute muscle injury. Med Sci Sports Exer 27:1022-1032, 1995.
61. Tidball JG, Berchenko E, Frenette J: Macrophage invasion does not contribute to muscle membrane injury during inflammation. J Leukoc Biol 65:492-498, 1999.
62. Tidball JG, Lavergne E, Lau KS, et al: Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle. Am J Physiol 275:260-266, 1998.
63. Tiidus PM: Radical species in inflammation and overtraining. Can J Physiol Pharm 76:533-538, 1998.
64. Van der Meulen JH, Kuipers H, Drukker J: Relationship between exercise-induced muscle damage and enzyme release in rats. J Appl Physiol 71:999-1004, 1991.
65. Vogt W, von Zabern I, Hesse D, et al: Generation of an activated form of human C5 (C5b-like C5) by oxygen radicals. Immunol Lett 14:209-215, 1986.
66. Ward C, Wong TH, Murray J et al: Induction of human neutrophil apoptosis by nitric oxide donors: Evidence for a caspase-dependent, cyclic-GMP-independent, mechanism. Biochem Pharmacol 59:305-314, 2000.
67. Wehling M, Spencer MJ, Tidball JG: A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 155:123-131, 2001.
68. Weisman HF, Barlow T, Leppo MK, et al: Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischaemic myocardial inflammation and necrosis. Science 249:146-151, 1990.
69. Wink DA, Cook JA, Pacelli R, et al: Nitric oxide (NO) protects against cellular damage by reactive oxygen species. Toxicol Lett 82-83:221-226, 1995.